These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

469 related items for PubMed ID: 16596267

  • 1. Antibody to hepatitis B core antigen is associated with the development of hepatocellular carcinoma in hepatitis C virus-infected persons: a 12-year prospective study.
    Tanaka K, Nagao Y, Ide T, Kumashiro R, Sata M.
    Int J Mol Med; 2006 May; 17(5):827-32. PubMed ID: 16596267
    [Abstract] [Full Text] [Related]

  • 2. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
    Adachi S, Shibuya A, Miura Y, Takeuchi A, Nakazawa T, Saigenji K.
    Scand J Gastroenterol; 2008 May; 43(7):849-56. PubMed ID: 18584524
    [Abstract] [Full Text] [Related]

  • 3. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis].
    Kim MJ, Kwon OS, Chung NS, Lee SY, Jung HS, Park DK, Ku YS, Kim YK, Kim YS, Kim JH.
    Korean J Hepatol; 2008 Mar; 14(1):67-76. PubMed ID: 18367859
    [Abstract] [Full Text] [Related]

  • 4. Lack of correlation between serum anti-HBcore detectability and hepatocellular carcinoma in patients with HCV-related cirrhosis.
    Stroffolini T, Almasio PL, Persico M, Bollani S, Benvegnù L, Di Costanzo G, Pastore G, Aghemo A, Stornaiuolo G, Mangia A, Andreone P, Stanzione M, Mazzella G, Saracco G, Del Poggio P, Bruno S, Italian Association of the Study of the Liver Disease (AISF).
    Am J Gastroenterol; 2008 Aug; 103(8):1966-72. PubMed ID: 18637087
    [Abstract] [Full Text] [Related]

  • 5. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
    Momosaki S, Nakashima Y, Kojiro M, Tabor E.
    J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
    [Abstract] [Full Text] [Related]

  • 6. Analysis of risk factors for hepatocellular carcinoma in patients with HBs antigen- and anti-HCV antibody-negative alcoholic cirrhosis: clinical significance of prior hepatitis B virus infection.
    Uetake S, Yamauchi M, Itoh S, Kawashima O, Takeda K, Ohata M.
    Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):47S-51S. PubMed ID: 12960507
    [Abstract] [Full Text] [Related]

  • 7. Clinical features of HBsAg-negative but anti-HBc-positive hepatocellular carcinoma in a hepatitis B virus endemic area.
    Shim J, Kim BH, Kim NH, Dong SH, Kim HJ, Chang YW, Lee JI, Chang R.
    J Gastroenterol Hepatol; 2005 May; 20(5):746-51. PubMed ID: 15853989
    [Abstract] [Full Text] [Related]

  • 8. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
    Kumar M, Kumar R, Hissar SS, Saraswat MK, Sharma BC, Sakhuja P, Sarin SK.
    J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381
    [Abstract] [Full Text] [Related]

  • 9. Hepatitis C and B virus infections in hepatocellular carcinoma. Analysis of direct detection of viral genome in paraffin embedded tissues.
    Edamoto Y, Tani M, Kurata T, Abe K.
    Cancer; 1996 May 01; 77(9):1787-91. PubMed ID: 8646675
    [Abstract] [Full Text] [Related]

  • 10. Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.
    Chen DS.
    Princess Takamatsu Symp; 1995 May 01; 25():27-32. PubMed ID: 8875606
    [Abstract] [Full Text] [Related]

  • 11. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study.
    Vaiphei K, Pal NS, Arora SK.
    Indian J Pathol Microbiol; 2006 Jul 01; 49(3):357-61. PubMed ID: 17001884
    [Abstract] [Full Text] [Related]

  • 12. Possible contribution of prior hepatitis B virus infection to the development of hepatocellular carcinoma.
    Tanaka H, Iwasaki Y, Nouso K, Kobayashi Y, Nakamura S, Matsumoto E, Toshikuni N, Kaneyoshi T, Ohsawa T, Takaguchi K, Fujio K, Senoh T, Ohnishi T, Sakaguchi K, Shiratori Y.
    J Gastroenterol Hepatol; 2005 Jun 01; 20(6):850-6. PubMed ID: 15946131
    [Abstract] [Full Text] [Related]

  • 13. Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study.
    Bruno S, Silini E, Crosignani A, Borzio F, Leandro G, Bono F, Asti M, Rossi S, Larghi A, Cerino A, Podda M, Mondelli MU.
    Hepatology; 1997 Mar 01; 25(3):754-8. PubMed ID: 9049231
    [Abstract] [Full Text] [Related]

  • 14. No evidence of hepatitis B virus activity in patients with anti-HBc antibody positivity with or without anti-hepatitis C virus antibody positivity.
    Haushofer AC, Hauer R, Brunner H, Köller U, Trubert-Exinger D, Halbmayer WM, Koidl C, Kessler HH.
    J Clin Virol; 2004 Apr 01; 29(4):221-3. PubMed ID: 15018848
    [Abstract] [Full Text] [Related]

  • 15. Frequency of isolated hepatitis B core antibody in HIV-hepatitis C virus co-infected individuals.
    Ramezani A, Mohraz M, Aghakhani A, Banifazl M, Eslamifar A, Khadem-Sadegh A, Velayati AA.
    Int J STD AIDS; 2009 May 01; 20(5):336-8. PubMed ID: 19386971
    [Abstract] [Full Text] [Related]

  • 16. Presence of antibodies to the hepatitis B surface antigen is associated with an excess risk for hepatocellular carcinoma among non-Asians in Los Angeles County, California.
    Yu MC, Yuan JM, Ross RK, Govindarajan S.
    Hepatology; 1997 Jan 01; 25(1):226-8. PubMed ID: 8985295
    [Abstract] [Full Text] [Related]

  • 17. Clinical features of hepatocellular carcinoma seronegative for both HBsAg and anti-HCV antibody but positive for anti-HBc antibody in Japan.
    Yano Y, Yamashita F, Sumie S, Ando E, Fukumori K, Kiyama M, Oyama T, Kuroki S, Kato O, Yamamoto H, Tanaka M, Sata M.
    Am J Gastroenterol; 2002 Jan 01; 97(1):156-61. PubMed ID: 11808941
    [Abstract] [Full Text] [Related]

  • 18. HBV DNA integration and HBV-transcript expression in non-B, non-C hepatocellular carcinoma in Japan.
    Tamori A, Nishiguchi S, Kubo S, Narimatsu T, Habu D, Takeda T, Hirohashi K, Shiomi S.
    J Med Virol; 2003 Dec 01; 71(4):492-8. PubMed ID: 14556260
    [Abstract] [Full Text] [Related]

  • 19. Influence of anti-HBc seropositivity on the risk of hepatocellular carcinoma in HCV-infected patients after adjusting for confounding factors.
    Ohki T, Tateishi R, Goto E, Sato T, Masuzaki R, Imamura J, Goto T, Kanai F, Kato N, Shiina S, Yoshida H, Kawabe T, Omata M.
    J Viral Hepat; 2010 Feb 01; 17(2):91-7. PubMed ID: 19566786
    [Abstract] [Full Text] [Related]

  • 20. Clinical significance of hepatitis C virus infection to alcoholics with cirrhosis in Korea.
    Kwon SY, Ahn MS, Chang HJ.
    J Gastroenterol Hepatol; 2000 Nov 01; 15(11):1282-6. PubMed ID: 11129222
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.